Kanishka Fernando, Hong Sheng Quah, Madhumathi Kalaichelvan, Hariraman Bhuvaneswari, Rahul Nagadia, Szymon Mikulski, Anuradha Thiagarajan, Eliza Fong, N Gopalakrishna Iyer. "PhaseX as a phase 0.9 translational platform to de-risk BiTE immunotherapy through mechanistic patient explant profiling.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.2615